Nuria Revilla-Calvo

7PUBLICATIONS
38CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyAutoimmunityFoetal development and medicineCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 30, 2026
Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

|Jul 16, 2025
Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk.

Ana Marín-Quílez, Ana Sánchez-Fuentes, Ana Zamora-Cánovas

|Jan 05, 2025
Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study).

Cristina Pascual-Izquierdo, Mª Jose Llacer-Ferrandis, Almudena de-la-Iglesia

|Mar 29, 2022
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease.

Verónica Palma-Barqueros, Nuria Revilla, Carlo Zaninetti

|Sep 13, 2021
Expanding the genetic spectrum of TUBB1-related thrombocytopenia.

Verónica Palma-Barqueros, Loredana Bury, Shinji Kunishima

|Aug 14, 2021
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Maria L Lozano, Maria E Mingot-Castellano, María M Perera

Pageof 2

Frequent Collaborators

5 joint publications

María Luisa Lozano

3 joint publications

José María Bastida

3 joint publications

Augustín Rodríguez-Alen

3 joint publications

José Rivera